Marinus Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch MRNS and buy or sell other stocks, ETFs, and their options commission-free!

About MRNS

Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid.

CEO

Anders Edvell, MD, PhD

CEOAnders Edvell, MD, PhD

Employees

—

Employees—

Headquarters

Radnor, Pennsylvania

HeadquartersRadnor, Pennsylvania

Founded

2003

Founded2003

Employees

—

Employees—

MRNS Key Statistics

Market cap

30.35M

Market cap30.35M

Price-Earnings ratio

-0.22

Price-Earnings ratio-0.22

Dividend yield

—

Dividend yield—

Average volume

333.56K

Average volume333.56K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$10.50

52 Week high$10.50

52 Week low

$0.2202

52 Week low$0.2202

People also own

Based on the portfolios of people who own MRNS. This list is generated using Robinhood data, and it’s not a recommendation.